Castle Biosciences, Inc.CSTLNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank25
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-42.81M
↓ 68% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-25.44M
Historical baseline
PeriodValueYoY Change
2025$-42.81M-593.8%
2024$8.67M+112.8%
2023$-67.98M+6.7%
2022$-72.86M-81.8%
2021$-40.08M-512.6%
2020$-6.54M-189.3%
2019$7.33M+291.1%
2018$-3.84M+64.8%
2017$-10.90M-